RS
Rekha Shah Pankaj
About Rekha Shah Pankaj
Data last updated:
Rekha Shah Pankaj is a Director at Epione Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Epione Pharmaceuticals Private Limited reported revenue of ₹12.66 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Epione Pharmaceuticals Private Limited U24233PN2012PTC143777 | Director | 10 Apr 2018 | 2012 | ₹12.66 Cr (FY 2024) | Active |
Board colleagues of Rekha Shah Pankaj
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pankaj Shah Sumatilal | 05124729 | Epione Pharmaceuticals Private Limited | Director |
| Rushika Shah Vipul | 07995110 | Epione Pharmaceuticals Private Limited | Director |
| Vipul Shah Pankaj | 05124740 | Epione Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rekha Shah Pankaj
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rekha Shah Pankaj
Rekha Shah Pankaj currently holds 1 directorship: Epione Pharmaceuticals Private Limited (Director, since 10 Apr 2018, revenue ₹12.66 Cr (FY 2024)).
Rekha Shah Pankaj was first appointed on 10 Apr 2018 as Director at Epione Pharmaceuticals Private Limited.
The current boards of Rekha Shah Pankaj's companies include Pankaj Shah Sumatilal (Epione Pharmaceuticals Private Limited), Rushika Shah Vipul (Epione Pharmaceuticals Private Limited), Vipul Shah Pankaj (Epione Pharmaceuticals Private Limited).